Biomechanical Study and Orthopedic Treatment Prevent in People With Diabetic Foot
FOOTprevent
Biomechanical Study of Patients With Diabetic Foot for the Establishment of a Preventive Orthopedic Treatment Protocol for Major Complications
1 other identifier
interventional
30
1 country
1
Brief Summary
Spain is the country with the second-highest rate of population amputation due to the development of ulcers, behind the United States, where 2 out of 3 non-traumatic amputations derive from diabetes. This is why the main objective of this project is to establish a study protocol for alterations in plantar pressures and gait abnormalities in diabetic patients, parallel to the preventive orthopedic treatment of major complications such as Charcot's foot, ulcers in the plantar support surface, and amputations. The study methodology will be based on the evaluation prior to the personalized orthopedic treatment for each patient and the evaluation after the orthopedic treatment, specifically at one week, one month, three months, and six months after the treatment. At each evaluation time, plantar pressure and reaction forces during walking and local infrared thermography will be analyzed. In the basal and final evaluation at six months, the muscular strength and range of motion of the lower limbs will also be evaluated. The orthopedic intervention is personalized to the requirements of the patients and is based on the use of an insole with the possible inclusion of orthopedic footwear in order to reduce plantar pressure.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Nov 2020
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 12, 2020
CompletedFirst Submitted
Initial submission to the registry
March 9, 2021
CompletedFirst Posted
Study publicly available on registry
March 12, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2023
CompletedDecember 8, 2022
December 1, 2022
3.1 years
March 9, 2021
December 7, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in the maximum plantar pressure (kPa)
Maximum plantar pressure (kPa) detected in the baseline measurement and after 6 months of the use of orthopedic treatment
6 months
Study Arms (1)
Orthopedic treatment
EXPERIMENTALParticipants who are referred for orthopedic treatment as indicated by the treating traumatologist or rehabilitating doctor will be evaluated and treated by one of the three orthopedists participating in this study. After the orthopedic evaluation, the professional will determine the most suitable insole according to the plantar discharge needs required by the patient. The intervention in the insole can include modifications or corrections at the forefoot, midfoot, or hindfoot. The material used in each insole will also be specified. When the insole requires many modifications and raises the height of the subject's foot, the use of orthopedic footwear will also be added to prevent pressure on the dorsum of the foot that could be caused by normal footwear.
Interventions
In each custom insole, modifications can be included in the following aspects according to the requirements of each participant : 1. Forefoot specifications: a) Retrocapital bar, b) Retrocapital support, c) Claw toe correction element, d) Pronating wedge, e) Supinator wedge, f) Metatarsal head pad, g) Selective perforations in the insole, h) Others. 2. Midfoot specifications: a) Internal arch, b) External arch, c) Full support, d) Excavations, e) Others. 3. Hindfoot specifications: a) Heel cup, b) Supinator wedge, c) Pronating wedge, d) Lifter, e) Cup, f) Others. 4. Insole type and lining material 5. Materials of the added corrections 6. Insole base: a) soft ethylene vinyl acetate (eva), b) semi-soft eva, c) hard eva, d) rubber, e) cuerolite.
Eligibility Criteria
You may qualify if:
- Patients with diabetic polyneuropathy
- Metatarsalgia with hyperkeratosis and/or claw fingers with diabetic polyneuropathy
- Support abnormalities in the coronal plane (supination/pronation)
- Plantar ulcers secondary to alterations in evolving and healed plantar pressures
- Charcot foot postoperative
You may not qualify if:
- Peripheral arterial disease (absence of distal pulses or ischemia)
- Active osteomyelitis
- Patients with prostheses after amputation
- Patients who travel mainly in a wheelchair due to gait abnormalities associated with other diseases.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Valencia
Valencia, 46010, Spain
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Francisco Forriols Brocal, PhD.
Orthopedic Surgery and Traumatology Service of the University Clinical Hospital of Valencia, Spain.
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Researcher
Study Record Dates
First Submitted
March 9, 2021
First Posted
March 12, 2021
Study Start
November 12, 2020
Primary Completion
December 1, 2023
Study Completion
December 1, 2023
Last Updated
December 8, 2022
Record last verified: 2022-12